Top Tweets for #Neogenomics
#NeoGenomics has expanded its partnership with Indica Labs, a global leader in AI-powered digital pathology: https://t.co/nx7urwlnLy.
Warren Stone, #NeoGenomics' current President and COO, has been appointed CEO and a member of the Board, effective January 4, 2027.
Tony Zook, current CEO and member of the Board, will transition to Executive Chair on January 4, 2027.
#BreastCancerAwarenessMonth begins today🎗️ All month long, we will be sharing education and resources, highlighting our testing solutions, and more.
#BreastCancerAwarenessMonth #BreastCancerAwareness2025 #CancerTesting #Oncology #NeoGenomics
RaDaR® ST provides clear, actionable answers: https://t.co/uMhtb5Vj8d.
#NeoGenomics #RaDaRST #PrecisionOncology #MRD
Wearing green for #MentalHealthAwareness 💚 At #NeoGenomics, we believe supporting mental health and well-being is just as important as supporting physical health. If you're interested in an organization committed to supporting emotional well-being, visit https://t.co/HDQFzaSvdJ.
As the NSCLC treatment landscape evolves, actionable biomarkers like c‑MET play an increasingly critical role. The c‑MET CDx for NSCLC IHC supports precision‑driven testing to guide targeted therapy decisions: https://t.co/ssIMzlXA19
#NeoGenomics #NSCLC #PrecisionMedicine #cMET
To obtain confidence in every result, and simplify complex myeloid cases, #NeoGenomics provides clarity: https://t.co/IbVJDDasYF
Neo Comprehensive – Myeloid Disorders uses DNA and RNA NGS to uncover actionable insights for MDS and CMML.
#MDS #CMML #Myeloid #HematologicalCancer
𝐑𝐞𝐚𝐥-𝐭𝐢𝐦𝐞 𝐚𝐥𝐞𝐫𝐭𝐬. 𝐒𝐦𝐚𝐫𝐭𝐞𝐫 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧𝐬. Stay ahead with NeoGenomics’ data triggers—patient and physician-level alerts that keep your strategy proactive, not reactive: https://t.co/wAp0tYjktg.
#OncologyInsights #DataTriggers #NeoGenomics
RaDaR® ST’s coverage helps ensure more patients can benefit from MRD-guided insights while giving your practice greater certainty and smoother billing workflows: https://t.co/EHCkIeKjxe.
#NeoGenomics #RaDaRST #PrecisionOncology #MRD
The #NeoGenomics oncology data solutions team is excited to be at #AACR26! Schedule a meeting with them here: https://t.co/5AMNT2thSe and learn more below about how multimodal data is driving the next era of translational research.
RaDaR® ST delivers intuitive, easy-to-interpret reports that translate complex molecular data into clear clinical guidance: https://t.co/2H4Bvzr6OG.
#NeoGenomics #RaDaRST #PrecisionOncology #MRD
PanTracer Pro ensures you have the insights tailored to your patient’s tumor type and clinical context needed to guide precision oncology: https://t.co/OKEHv4vmZj
#Oncology #PanTracerPro #NeoGenomics #CancerTesting
AI is transforming oncology. Explore how digital pathology and AI are reshaping screening and diagnosis in our new white paper: https://t.co/wAp0tYjktg
#AIDigitalPathology #PrecisionOncology #NeoGenomics
New white paper! From Data to Decision: Biomarkers Driving Precision Medicine: https://t.co/wAp0tYjktg. Gastric cancer remains the 4th leading cause of cancer-related death worldwide, but #biomarker-driven therapies are changing the game.
#OncologyData #NeoGenomics
We can’t wait to meet you! Visit #NeoGenomics at booth #639 at the USCAP 115th Annual Meeting to explore innovations driving precision oncology forward. #USCAP2026 #Pathology #OncologyDiagnostics
Wherever the signal starts, you can find it with RaDaR ST: https://t.co/OgWowWlT4t
Its highly sensitive MRD technology detects tumor DNA, long before imaging, revealing the earliest signs of recurrence and supports timely, confident decisions.
#NeoGenomics #PrecisionOncology
RaDaR® ST minimizes false positives and supports precise, timely care decisions: https://t.co/OgWowWlT4t.
#NeoGenomics #RaDaRST #PrecisionOncology #MRD
.
.
.
*Detection down to 1 part per million (ppm) under study-specific conditions
RaDaR® ST is supported by a growing foundation of clinical evidence. https://t.co/OgWowWlT4t.
#NeoGenomics #RaDaRST #PrecisionOncology #MRD
RaDaR® ST identifies the unique tumor profile of each patient to provide clear answers: https://t.co/OgWowWlT4t.
#NeoGenomics #RaDaRST #PrecisionOncology #MRD
Neo Comprehensive® – Myeloid Disorders, a CGP NGS assay, delivers clear and precise results for myeloid disorders, including MDS and CMML, helping clinicians make confident decisions. https://t.co/0tPKXGAxTd
#NeoGenomics #CancerTesting #OncologyInsights
Last Seen Hashtags on Sotwe
minichat
Seen from Turkey
kontolin
Seen from Vietnam
anxiouspandq
şişmanbayan
Seen from Turkey
hidden cam sex
Seen from Turkey
Çeşmeescort
Seen from Germany
minichat((((*))))* filter:videos
Seen from Turkey
anxiouspandaa
Seen from Mexico
Anaimiya
Seen from Indonesia
ديااثة()filter:native_video
Seen from Singapore
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers